The CRISPR-led gene-editing revolution is set to begin next month in its first ever trial in humans. The small phase 1 trial, to take place in China, will be investigating the method’s safety ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

The World Health Organization (WHO) has played down the transmission risk of a recently reported bird flu case in China. The WHO said Tuesday that it had assessed the risk of human-to-human ...

There are many processes by which human–animal chimera’s can be created ... However, in 2015, China became the first country to publish data on CRISPR/Cas9 gene editing in human zygotes and recently ...

In China, CRISPR was used in cases where the male partner was HIV-positive. According to MIT Technology Review, Zhou & Silva (2016) showed that the deletion of CCR5 not only makes mice smarter but ...

The genetics researcher took it upon himself to use the CRISPR gene-editing technique to modify human embryos and then have those embryos carried to term by their mothers. This resulted in what ...

The first US trials using CRISPR, being spearheaded by the University of Pennsylvania, are slated to begin soon, but scientists in China have already been using it for years. The first few dozen ...